Noile-Immune Biotech Inc. — Investor Relations & Filings
Noile-Immune Biotech Inc. is a clinical-stage biotechnology company focused on the development and commercialization of novel cancer immunotherapies. The company specializes in next-generation Chimeric Antigen Receptor T-cell (CAR-T) therapies, leveraging its proprietary PRIME (Proliferation-Inducing and Migration-Enhancing) technology. This platform is designed to enhance the efficacy of CAR-T cells by enabling them to produce specific cytokines and chemokines, thereby improving their proliferation, persistence, and ability to infiltrate the tumor microenvironment. A primary goal is to develop effective treatments for solid tumors, a significant challenge for conventional cell therapies. The company advances its pipeline through internal research and development as well as strategic partnerships.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Adaptimmune社との提携契約の終了のお知らせ | 2026-05-18 | Japanese | |
| 2026年12月期 第１四半期決算短信〔日本基準〕（非連結） | 2026-05-14 | Japanese | |
| 譲渡制限付株式報酬としての新株式発行に関するお知らせ | 2026-04-15 | Japanese | |
| 確認書 | 2026-03-23 | Japanese | |
| 有価証券報告書－第11期(2025/01/01－2025/12/31) | 2026-03-23 | Japanese | |
| 2025年12月期 決算短信〔日本基準〕（非連結） | 2026-02-13 | Japanese |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 46541380 | Adaptimmune社との提携契約の終了のお知らせ | 2026-05-18 | Japanese | ||
| 48204991 | 2026年12月期 第１四半期決算短信〔日本基準〕（非連結） | 2026-05-14 | Japanese | ||
| 46877295 | 譲渡制限付株式報酬としての新株式発行に関するお知らせ | 2026-04-15 | Japanese | ||
| 33010397 | 確認書 | 2026-03-23 | Japanese | ||
| 33010395 | 有価証券報告書－第11期(2025/01/01－2025/12/31) | 2026-03-23 | Japanese | ||
| 48204992 | 2025年12月期 決算短信〔日本基準〕（非連結） | 2026-02-13 | Japanese | ||
|
2025
9 filings
| |||||
| 48204993 | 2025年12月期 第３四半期決算短信〔日本基準〕（非連結） | 2025-11-13 | Japanese | ||
| 7858942 | 確認書 | 2025-08-08 | Japanese | ||
| 7858941 | 半期報告書－第11期(2025/01/01－2025/12/31) | 2025-08-08 | Japanese | ||
| 48204994 | 2025年12月期 第２四半期（中間期）決算短信〔日本基準〕（非連結） | 2025-08-08 | Japanese | ||
| 48204995 | 2025年12月期 第１四半期決算短信〔日本基準〕（非連結） | 2025-05-12 | Japanese | ||
| 7268845 | 臨時報告書 | 2025-04-01 | Japanese | ||
| 7270245 | 確認書 | 2025-03-28 | Japanese | ||
| 7270239 | 内部統制報告書－第10期(2024/01/01－2024/12/31) | 2025-03-28 | Japanese | ||
| 7270247 | 有価証券報告書－第10期(2024/01/01－2024/12/31) | 2025-03-28 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Noile-Immune Biotech Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/14610/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=14610 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=14610 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=14610 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 14610}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Noile-Immune Biotech Inc. (id: 14610)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.